APO Research
Talk to an analyst

APO RESEARCH · REPORT

Famciclovir API

Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)

Selected research

Industry Growth & Trends

Global Famciclovir API Industry Growth and Trends Forecast to 2032

28 December 2025108 pages

Choose your research edition.

Industry ResearchFamciclovir API Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Famciclovir API Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Famciclovir API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Famciclovir API Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Famciclovir API Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Famciclovir is a guanosine analogue antiviral drug used for the treatment of various herpesvirus infections, most commonly for herpes zoster (shingles). It is a prodrug form of penciclovir with improved oral bioavailability. Famciclovir is marketed under the trade name Famvir (Novartis)

The classification of Famciclovir API includes Insourced and Outsourced. In addition, the proportion of Insulin Outsourced in 2019 is about 71%, and the proportion is in increasing trend from 2015 to 2020.

Famciclovir API is widely used in Tablet Product, Capsule Product and Others Product. The most proportion of Famciclovir API is used in Tablet Product, and the proportion in 2019 is about 80%.

Read the full market overview

Asia-Pacific is the largest consumption market, with a market share nearly 48% in 2019. Following Asia-Pacific, North America is the second largest consumption market with the market share of about 21%.

Market competition is intense. Chongqing Shenghuaxi Pharma, Aurobindo Pharma Limited, Apotex Pharmachem, Changzhou Kony Pharma Co, Teva Pharmaceutical Industries, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report provides a structured, data-driven view of the global Famciclovir API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Famciclovir API market size, estimates, and forecasts are presented in terms of sales volume (KG) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Famciclovir API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Famciclovir API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Famciclovir API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Famciclovir API Market by Company

Chongqing Shenghuaxi Pharma

Aurobindo Pharma Limited

Apotex Pharmachem

Changzhou Kony Pharma Co

Teva Pharmaceutical Industries

Olon

Fuan Pharmaceutical

Zhejiang Charioteer Pharmaceutical

Jialin Pharmaceutical

Zhejiang Hisun

Hetero

Famciclovir API Segment by Type

Insourced

Outsourced

Others

Famciclovir API Segment by Application

Tablet Product

Capsule Product

Others

Famciclovir API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Famciclovir API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Famciclovir API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Famciclovir API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Famciclovir API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Famciclovir API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Insourced Table 2. Major Company of Outsourced Table 3. Major Company of Others Table 4. Global Famciclovir API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Famciclovir API Sales by Type (2021-2026) & (KG) Table 6. Global Famciclovir API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Famciclovir API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Famciclovir API Sales Market Share in Value by Type (2021-2026) Table 9. Global Famciclovir API Price by Type (2021-2026) & (US$/KG) Table 10. Global Famciclovir API Sales by Type (2027-2032) & (KG) Table 11. Global Famciclovir API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Famciclovir API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Famciclovir API Sales Market Share in Value by Type (2027-2032) Table 14. Global Famciclovir API Price by Type (2027-2032) & (US$/KG) Table 15. North America Famciclovir API Sales by Type (2021-2026) & (KG) Table 16. North America Famciclovir API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Famciclovir API Sales by Type (2021-2026) & (KG) Table 18. Europe Famciclovir API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Famciclovir API Sales by Type (2021-2026) & (KG) Table 20. Asia-Pacific Famciclovir API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Famciclovir API Sales by Type (2021-2026) & (KG) Table 22. Latin America Famciclovir API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Famciclovir API Sales by Type (2021-2026) & (KG) Table 24. Middle East and Africa Famciclovir API Sales by Type (2021-2026) & (US$ Million) Table 25. Famciclovir API Industry Trends Table 26. Famciclovir API Industry Drivers Table 27. Famciclovir API Industry Opportunities and Challenges Table 28. Famciclovir API Industry Restraints Table 29. Global Famciclovir API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Famciclovir API Revenue Market Share by Company (2021-2026) Table 31. Global Famciclovir API Sales by Company (2021-2026) & (KG) Table 32. Global Famciclovir API Sales Share by Company (2021-2026) Table 33. Global Famciclovir API Market Price by Company (2021-2026) & (US$/KG) Table 34. Global Famciclovir API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Famciclovir API Major Company Production Sites and Headquarters Table 36. Global Famciclovir API Company, Product Type & Application Table 37. Global Famciclovir API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Famciclovir API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Famciclovir API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Famciclovir API Sales by Region (2021-2026) & (KG) Table 42. Global Famciclovir API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Famciclovir API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Famciclovir API Sales Market Share in Value by Region (2021-2026) Table 45. Global Famciclovir API Sales (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 46. Global Famciclovir API Sales by Region (2027-2032) & (KG) Table 47. Global Famciclovir API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Famciclovir API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Famciclovir API Sales Market Share in Value by Region (2027-2032) Table 50. Global Famciclovir API Sales (KG), Value (US$ Million), Price (US$/KG) and Gross Margin (2027-2032) Table 51. Global Famciclovir API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Famciclovir API Sales by Application (2021-2026) & (KG) Table 53. Global Famciclovir API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Famciclovir API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Famciclovir API Sales Market Share in Value by Application (2021-2026) Table 56. Global Famciclovir API Price by Application (2021-2026) & (US$/KG) Table 57. Global Famciclovir API Sales by Application (2027-2032) & (KG) Table 58. Global Famciclovir API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Famciclovir API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Famciclovir API Sales Market Share in Value by Application (2027-2032) Table 61. Global Famciclovir API Price by Application (2027-2032) & (US$/KG) Table 62. North America Famciclovir API Sales by Application (2021-2026) & (KG) Table 63. North America Famciclovir API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Famciclovir API Sales by Application (2021-2026) & (KG) Table 65. Europe Famciclovir API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Famciclovir API Sales by Application (2021-2026) & (KG) Table 67. Asia-Pacific Famciclovir API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Famciclovir API Sales by Application (2021-2026) & (KG) Table 69. Latin America Famciclovir API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Famciclovir API Sales by Application (2021-2026) & (KG) Table 71. Middle East and Africa Famciclovir API Sales by Application (2021-2026) & (US$ Million) Table 72. Chongqing Shenghuaxi Pharma Company Information Table 73. Chongqing Shenghuaxi Pharma Business Overview Table 74. Chongqing Shenghuaxi Pharma Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 75. Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolio Table 76. Chongqing Shenghuaxi Pharma Recent Development Table 77. Aurobindo Pharma Limited Company Information Table 78. Aurobindo Pharma Limited Business Overview Table 79. Aurobindo Pharma Limited Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 80. Aurobindo Pharma Limited Famciclovir API Product Portfolio Table 81. Aurobindo Pharma Limited Recent Development Table 82. Apotex Pharmachem Company Information Table 83. Apotex Pharmachem Business Overview Table 84. Apotex Pharmachem Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 85. Apotex Pharmachem Famciclovir API Product Portfolio Table 86. Apotex Pharmachem Recent Development Table 87. Changzhou Kony Pharma Co Company Information Table 88. Changzhou Kony Pharma Co Business Overview Table 89. Changzhou Kony Pharma Co Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 90. Changzhou Kony Pharma Co Famciclovir API Product Portfolio Table 91. Changzhou Kony Pharma Co Recent Development Table 92. Teva Pharmaceutical Industries Company Information Table 93. Teva Pharmaceutical Industries Business Overview Table 94. Teva Pharmaceutical Industries Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 95. Teva Pharmaceutical Industries Famciclovir API Product Portfolio Table 96. Teva Pharmaceutical Industries Recent Development Table 97. Olon Company Information Table 98. Olon Business Overview Table 99. Olon Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 100. Olon Famciclovir API Product Portfolio Table 101. Olon Recent Development Table 102. Fuan Pharmaceutical Company Information Table 103. Fuan Pharmaceutical Business Overview Table 104. Fuan Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 105. Fuan Pharmaceutical Famciclovir API Product Portfolio Table 106. Fuan Pharmaceutical Recent Development Table 107. Zhejiang Charioteer Pharmaceutical Company Information Table 108. Zhejiang Charioteer Pharmaceutical Business Overview Table 109. Zhejiang Charioteer Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 110. Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolio Table 111. Zhejiang Charioteer Pharmaceutical Recent Development Table 112. Jialin Pharmaceutical Company Information Table 113. Jialin Pharmaceutical Business Overview Table 114. Jialin Pharmaceutical Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 115. Jialin Pharmaceutical Famciclovir API Product Portfolio Table 116. Jialin Pharmaceutical Recent Development Table 117. Zhejiang Hisun Company Information Table 118. Zhejiang Hisun Business Overview Table 119. Zhejiang Hisun Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 120. Zhejiang Hisun Famciclovir API Product Portfolio Table 121. Zhejiang Hisun Recent Development Table 122. Hetero Company Information Table 123. Hetero Business Overview Table 124. Hetero Famciclovir API Sales (KG), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2021-2026) Table 125. Hetero Famciclovir API Product Portfolio Table 126. Hetero Recent Development Table 127. North America Famciclovir API Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 128. North America Famciclovir API Sales by Country (2021-2026) & (KG) Table 129. North America Famciclovir API Sales Market Share by Country (2021-2026) Table 130. North America Famciclovir API Sales Forecast by Country (2027-2032) & (KG) Table 131. North America Famciclovir API Sales Market Share Forecast by Country (2027-2032) Table 132. North America Famciclovir API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Famciclovir API Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Famciclovir API Market Share by Country (2021-2026) Table 135. North America Famciclovir API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Famciclovir API Market Share Forecast by Country (2027-2032) Table 137. Europe Famciclovir API Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 138. Europe Famciclovir API Sales by Country (2021-2026) & (KG) Table 139. Europe Famciclovir API Sales Market Share by Country (2021-2026) Table 140. Europe Famciclovir API Sales Forecast by Country (2027-2032) & (KG) Table 141. Europe Famciclovir API Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Famciclovir API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Famciclovir API Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Famciclovir API Market Share by Country (2021-2026) Table 145. Europe Famciclovir API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Famciclovir API Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Famciclovir API Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Famciclovir API Sales by Country (2021-2026) & (KG) Table 149. Asia-Pacific Famciclovir API Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Famciclovir API Sales Forecast by Country (2027-2032) & (KG) Table 151. Asia-Pacific Famciclovir API Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Famciclovir API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Famciclovir API Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Famciclovir API Market Share by Country (2021-2026) Table 155. Asia-Pacific Famciclovir API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Famciclovir API Market Share Forecast by Country (2027-2032) Table 157. Latin America Famciclovir API Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 158. Latin America Famciclovir API Sales by Country (2021-2026) & (KG) Table 159. Latin America Famciclovir API Sales Market Share by Country (2021-2026) Table 160. Latin America Famciclovir API Sales Forecast by Country (2027-2032) & (KG) Table 161. Latin America Famciclovir API Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Famciclovir API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Famciclovir API Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Famciclovir API Market Share by Country (2021-2026) Table 165. Latin America Famciclovir API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Famciclovir API Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Famciclovir API Market Size Growth Rate (CAGR) by Country (KG): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Famciclovir API Sales by Country (2021-2026) & (KG) Table 169. Middle East and Africa Famciclovir API Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Famciclovir API Sales Forecast by Country (2027-2032) & (KG) Table 171. Middle East and Africa Famciclovir API Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Famciclovir API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Famciclovir API Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Famciclovir API Market Share by Country (2021-2026) Table 175. Middle East and Africa Famciclovir API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Famciclovir API Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Famciclovir API Distributors List Table 180. Famciclovir API Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Famciclovir API Image Figure 2. Global Famciclovir API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Famciclovir API Market Size (2021-2032) & (US$ Million) Figure 4. Global Famciclovir API Sales (2021-2032) & (KG) Figure 5. Insourced Image Figure 6. Global Insourced Sales YoY Growth (2021-2032) & (KG) Figure 7. Outsourced Image Figure 8. Global Outsourced Sales YoY Growth (2021-2032) & (KG) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (KG) Figure 11. Global Famciclovir API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Famciclovir API Market Share by Type 2025 VS 2032 Figure 13. North America Famciclovir API Sales Market Share in Volume by Type in 2025 Figure 14. North America Famciclovir API Sales Market Share in Value by Type in 2025 Figure 15. Europe Famciclovir API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Famciclovir API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Famciclovir API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Famciclovir API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Famciclovir API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Famciclovir API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Famciclovir API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Famciclovir API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Famciclovir API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Tablet Product Image Figure 26. Global Tablet Product Sales YoY Growth (2021-2032) & (KG) Figure 27. Capsule Product Image Figure 28. Global Capsule Product Sales YoY Growth (2021-2032) & (KG) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (KG) Figure 31. Global Famciclovir API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Famciclovir API Market Share by Application 2025 VS 2032 Figure 33. North America Famciclovir API Sales Market Share in Volume by Application in 2025 Figure 34. North America Famciclovir API Sales Market Share in Value by Application in 2025 Figure 35. Europe Famciclovir API Sales Market Share in Volume by Application in 2025 Figure 36. Europe Famciclovir API Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Famciclovir API Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Famciclovir API Sales Market Share in Value by Application in 2025 Figure 39. Latin America Famciclovir API Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Famciclovir API Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Famciclovir API Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Famciclovir API Sales Market Share in Value by Application in 2025 Figure 43. North America Famciclovir API Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 44. North America Famciclovir API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Famciclovir API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Famciclovir API Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 48. Europe Famciclovir API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Famciclovir API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Famciclovir API Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 52. Asia-Pacific Famciclovir API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Famciclovir API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Famciclovir API Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 56. Latin America Famciclovir API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Famciclovir API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Famciclovir API Sales by Country: 2021 VS 2025 VS 2032 (KG) Figure 60. Middle East and Africa Famciclovir API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Famciclovir API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Famciclovir API Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Famciclovir API Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Famciclovir API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Insourced
  • Outsourced
  • Others
Applications
  • Tablet Product
  • Capsule Product
  • Others
Companies covered
  • Chongqing Shenghuaxi Pharma
  • Aurobindo Pharma Limited
  • Apotex Pharmachem
  • Changzhou Kony Pharma Co
  • Teva Pharmaceutical Industries
  • Olon
  • Fuan Pharmaceutical
  • Zhejiang Charioteer Pharmaceutical
  • Jialin Pharmaceutical
  • Zhejiang Hisun
  • Hetero

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Famciclovir API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Famciclovir API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Famciclovir API Market by Type
  6. 1.3.1 Insourced
  7. 1.3.2 Outsourced
  8. 1.3.3 Others
  9. 1.4 Global Famciclovir API Market Size by Type
  10. 1.4.1 Global Famciclovir API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Famciclovir API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Famciclovir API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Famciclovir API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Famciclovir API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Famciclovir API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Famciclovir API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Famciclovir API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Famciclovir API Industry Trends
  2. 2.2 Famciclovir API Industry Drivers
  3. 2.3 Famciclovir API Industry Opportunities and Challenges
  4. 2.4 Famciclovir API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Famciclovir API Revenue (2021-2026)
  2. 3.2 Global Top Players by Famciclovir API Sales (2021-2026)
  3. 3.3 Global Top Players by Famciclovir API Price (2021-2026)
  4. 3.4 Global Famciclovir API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Famciclovir API Major Company Production Sites & Headquarters
  6. 3.6 Global Famciclovir API Company, Product Type & Application
  7. 3.7 Global Famciclovir API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Famciclovir API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Famciclovir API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Famciclovir API Tier 1, Tier 2, and Tier 3
4 Famciclovir API Regional Status and Outlook
  1. 4.1 Global Famciclovir API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Famciclovir API Historic Market Size by Region
  3. 4.2.1 Global Famciclovir API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Famciclovir API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Famciclovir API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Famciclovir API Forecasted Market Size by Region
  7. 4.3.1 Global Famciclovir API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Famciclovir API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Famciclovir API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Famciclovir API by Application
  1. 5.1 Famciclovir API Market by Application
  2. 5.1.1 Tablet Product
  3. 5.1.2 Capsule Product
  4. 5.1.3 Others
  5. 5.2 Global Famciclovir API Market Size by Application
  6. 5.2.1 Global Famciclovir API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Famciclovir API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Famciclovir API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Famciclovir API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Famciclovir API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Famciclovir API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Famciclovir API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Famciclovir API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chongqing Shenghuaxi Pharma
  2. 6.1.1 Chongqing Shenghuaxi Pharma Company Information
  3. 6.1.2 Chongqing Shenghuaxi Pharma Business Overview
  4. 6.1.3 Chongqing Shenghuaxi Pharma Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chongqing Shenghuaxi Pharma Famciclovir API Product Portfolio
  6. 6.1.5 Chongqing Shenghuaxi Pharma Recent Developments
  7. 6.2 Aurobindo Pharma Limited
  8. 6.2.1 Aurobindo Pharma Limited Company Information
  9. 6.2.2 Aurobindo Pharma Limited Business Overview
  10. 6.2.3 Aurobindo Pharma Limited Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aurobindo Pharma Limited Famciclovir API Product Portfolio
  12. 6.2.5 Aurobindo Pharma Limited Recent Developments
  13. 6.3 Apotex Pharmachem
  14. 6.3.1 Apotex Pharmachem Company Information
  15. 6.3.2 Apotex Pharmachem Business Overview
  16. 6.3.3 Apotex Pharmachem Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Apotex Pharmachem Famciclovir API Product Portfolio
  18. 6.3.5 Apotex Pharmachem Recent Developments
  19. 6.4 Changzhou Kony Pharma Co
  20. 6.4.1 Changzhou Kony Pharma Co Company Information
  21. 6.4.2 Changzhou Kony Pharma Co Business Overview
  22. 6.4.3 Changzhou Kony Pharma Co Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Changzhou Kony Pharma Co Famciclovir API Product Portfolio
  24. 6.4.5 Changzhou Kony Pharma Co Recent Developments
  25. 6.5 Teva Pharmaceutical Industries
  26. 6.5.1 Teva Pharmaceutical Industries Company Information
  27. 6.5.2 Teva Pharmaceutical Industries Business Overview
  28. 6.5.3 Teva Pharmaceutical Industries Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Teva Pharmaceutical Industries Famciclovir API Product Portfolio
  30. 6.5.5 Teva Pharmaceutical Industries Recent Developments
  31. 6.6 Olon
  32. 6.6.1 Olon Company Information
  33. 6.6.2 Olon Business Overview
  34. 6.6.3 Olon Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Olon Famciclovir API Product Portfolio
  36. 6.6.5 Olon Recent Developments
  37. 6.7 Fuan Pharmaceutical
  38. 6.7.1 Fuan Pharmaceutical Company Information
  39. 6.7.2 Fuan Pharmaceutical Business Overview
  40. 6.7.3 Fuan Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Fuan Pharmaceutical Famciclovir API Product Portfolio
  42. 6.7.5 Fuan Pharmaceutical Recent Developments
  43. 6.8 Zhejiang Charioteer Pharmaceutical
  44. 6.8.1 Zhejiang Charioteer Pharmaceutical Company Information
  45. 6.8.2 Zhejiang Charioteer Pharmaceutical Business Overview
  46. 6.8.3 Zhejiang Charioteer Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Zhejiang Charioteer Pharmaceutical Famciclovir API Product Portfolio
  48. 6.8.5 Zhejiang Charioteer Pharmaceutical Recent Developments
  49. 6.9 Jialin Pharmaceutical
  50. 6.9.1 Jialin Pharmaceutical Company Information
  51. 6.9.2 Jialin Pharmaceutical Business Overview
  52. 6.9.3 Jialin Pharmaceutical Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Jialin Pharmaceutical Famciclovir API Product Portfolio
  54. 6.9.5 Jialin Pharmaceutical Recent Developments
  55. 6.10 Zhejiang Hisun
  56. 6.10.1 Zhejiang Hisun Company Information
  57. 6.10.2 Zhejiang Hisun Business Overview
  58. 6.10.3 Zhejiang Hisun Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Zhejiang Hisun Famciclovir API Product Portfolio
  60. 6.10.5 Zhejiang Hisun Recent Developments
  61. 6.11 Hetero
  62. 6.11.1 Hetero Company Information
  63. 6.11.2 Hetero Business Overview
  64. 6.11.3 Hetero Famciclovir API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Hetero Famciclovir API Product Portfolio
  66. 6.11.5 Hetero Recent Developments
7 North America by Country
  1. 7.1 North America Famciclovir API Sales by Country
  2. 7.1.1 North America Famciclovir API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Famciclovir API Sales by Country (2021-2026)
  4. 7.1.3 North America Famciclovir API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Famciclovir API Market Size by Country
  6. 7.2.1 North America Famciclovir API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Famciclovir API Market Size by Country (2021-2026)
  8. 7.2.3 North America Famciclovir API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Famciclovir API Sales by Country
  2. 8.1.1 Europe Famciclovir API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Famciclovir API Sales by Country (2021-2026)
  4. 8.1.3 Europe Famciclovir API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Famciclovir API Market Size by Country
  6. 8.2.1 Europe Famciclovir API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Famciclovir API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Famciclovir API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Famciclovir API Sales by Country
  2. 9.1.1 Asia-Pacific Famciclovir API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Famciclovir API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Famciclovir API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Famciclovir API Market Size by Country
  6. 9.2.1 Asia-Pacific Famciclovir API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Famciclovir API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Famciclovir API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Famciclovir API Sales by Country
  2. 10.1.1 South America Famciclovir API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Famciclovir API Sales by Country (2021-2026)
  4. 10.1.3 South America Famciclovir API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Famciclovir API Market Size by Country
  6. 10.2.1 South America Famciclovir API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Famciclovir API Market Size by Country (2021-2026)
  8. 10.2.3 South America Famciclovir API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Famciclovir API Sales by Country
  2. 11.1.1 Middle East and Africa Famciclovir API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Famciclovir API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Famciclovir API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Famciclovir API Market Size by Country
  6. 11.2.1 Middle East and Africa Famciclovir API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Famciclovir API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Famciclovir API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Famciclovir API Value Chain Analysis
  2. 12.1.1 Famciclovir API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Famciclovir API Production Mode & Process
  7. 12.2 Famciclovir API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Famciclovir API Distributors
  10. 12.2.3 Famciclovir API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst